LONG-TERM hGH TREATMENT OF SHORT PREPUBERTAL CHILDREN IMPROVES THEIR HEIGHT

Forty-six short children classified as familial short stature (FSS) or intrautcrinc growth retardation (1UGR) and normal GH reserve (≥ 10 ng/ml) were t recited with rhCH (Norditropin - Novo/Nordisk, 0.1 U/kg/d) for periods between 24-30 months. Their age ranged from 2.6 to 10 yrs (7 F, 39 M). The body measurements and hone age (BA) estimations were made by the same persons. The changes in SDS height registered were as follows: